RE:RE:RE:I blame Andrew for this crappy few days.I see where you're coming from. It would be good to have someone separate in charge of investor relations, but I think there's a very fine line as to what can be said right now. If there are non-disclosure agreements in place, there's not too much Andrew can tell us other than what's already been said. He participated in an interview on pinnacle digest earlier this month which was very positive. From the sounds of it, there's a lot going on, and the information will be made public in the near term. Today was a red market and the sell-off was overdone in my opinion. Sure they don't have revenues, but neither does CXV, PTK, or PLI. You can't value tech and bio companies based off revenues alone. There's tremendous value in YFI's patent portfolio and what remains unknown is just how valuable it is. Revenues are just starting to come in with multiple pilots to be launched in the upcoming quarter. The problem here is the unknown. We're all trying to connect the dots, but it's impossible until further information is made available. I'm not trying to promote YFI. Like I said before, if this drops to $.13 or $.10, I won't be losing sleep. I'll be envious of those able to purchase shares at such a discount, but I'm interested in the long-term value of my investment. I again added to my position today and plan to continue to do so with any further weakness. Liquidity is a beautiful thing when things go south for no reason. Good luck.